We hope you’re enjoying the strong market, and also remembering to pay yourself from time to time from your profits. Our featured stock for November is a tiny company with big dreams ... of using a common natural virus to attack and kill cancer cells. As with all development-stage biotechs, the risks are high. But if all works as management hopes, the payoff will be huge. You’ll find full details in the issue.
